XML 21 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating activities:      
Net income $ 32,988 $ 48,854 $ 74,246
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 3,539 3,688 3,475
Amortization of premium and accretion of discount on securities, net 242 578 2,665
Amortization of restricted stock 5,788 10,751 8,382
Amortization of intangible assets 1,088 1,319 1,569
Amortization of subordinated debt costs 287 287 286
Provision for credit losses [1] 7,500 14,091 6,353
Swap valuation allowance     673
Stock-based compensation and employee stock purchase plan expense 154 178 145
Deferred tax benefit (14,297) (15,276) (6,641)
Fair value adjustment for equity security (828) (181) 1,700
Loss on sale of securities, available for sale, net     6,609
Proceeds from sales of loans held for sale [2] 28,886 41,355 98,568
Loans originated for sale [2] (29,308) (30,000) (74,856)
Gain on loans held for sale [2] (1,377) (2,524) (7,248)
Gain on loans held for sale at lower of cost or fair value (23)    
Loss/(gain) on disposal of fixed assets 102 6 (275)
Gain on life insurance death benefit (236) (41) (27)
Increase in cash surrender value of life insurance, net (318) (457) (532)
Decrease/(increase) in accrued interest receivable 778 (5,519) (3,568)
(Increase)/decrease in other assets (27,055) (3,324) 5,261
Increase in accrued expenses and other liabilities 63,193 6,295 2,116
Net cash provided by operating activities 71,103 70,080 118,901
Investing activities:      
Principal repayments, maturities and calls of securities held to maturity 6,034 4,803 6,286
Principal repayments, maturities and calls of securities available for sale 661,474 633,737 440,668
Redemptions for FHLB & FRB stock 59,709 115,947 33,804
Sales of securities available for sale     118,972
Proceeds from sales of equity securities 953    
Purchase of securities held to maturity   (10,347)  
Purchase of securities available for sale (899,669) (619,025) (420,169)
Purchase of FHLB & FRB stock (41,038) (116,319) (51,526)
Proceeds from sale of loans held for sale at lower of cost or fair value 23    
Net increase in loans, net of participations sold (83,397) (153,112) (480,862)
Sales of OREO   116  
Purchases of premises and equipment (8,097) (3,275) (3,517)
Disposal of premises and equipment 428 (6) 277
Proceeds from life insurance death benefit 154    
Net cash used in investing activities (303,426) (147,481) (356,067)
Financing activities:      
Net increase/(decrease) in deposits 854,908 68,950 (60,985)
Net (decrease)/increase in short-term borrowings (403,814) 24,284 379,530
Dividends paid on common stock (3,530) (3,558) (3,645)
Exercise of stock options, net of stock swaps   42 292
Restricted stock repurchased on vesting to pay taxes (877) (3,243) (2,937)
Issuance of restricted stock (4,336) 0 0
Issuance of shares for employee stock purchase plan 857 1,016 904
Shares repurchased (7,189) (12,494) (32,722)
Net cash provided by financing activities 436,019 74,997 280,437
Net (decrease)/increase in cash and cash equivalents 203,696 (2,404) 43,271
Cash and cash equivalents at beginning of period 187,671 190,075 146,804
Cash and cash equivalents at end of period 391,367 187,671 190,075
Cash paid during the period for:      
Interest 170,801 141,166 33,158
Income tax, net 17,672 18,474 25,002
Transfer of loans to other real estate owned     116
Right-of-use asset obtained in exchange for operating lease liabilities $ 32,302 $ 1,926 $ 5,909
[1] Commencing on January 1, 2022, the allowance calculation is based on the CECL methodology. Prior to January 1, 2022, the calculation was based on the incurred loss methodology.
[2] Includes mortgage loans originated with the intent to sell which are carried at fair value. In addition, includes the guaranteed portion of SBA loans, which are carried at the lower of cost or fair value.